FindAPhD Weekly PhD Newsletter | JOIN NOW FindAPhD Weekly PhD Newsletter | JOIN NOW

Designing inhibitors of essential protein-interactions for bacterial cell division (BEEKMANA_U22SF)

   School of Pharmacy

This project is no longer listed on and may not be available.

Click here to search for PhD studentship opportunities
  Dr A Beekman, Dr S Schlimpert  No more applications being accepted  Self-Funded PhD Students Only

About the Project

Antibiotic-resistant pathogens are a huge threat in healthcare. The last resorts of conventional antibiotic drugs are unable to treat multi-resistant strains in patients. New approaches towards antibiotics are desperately needed. To spread and survive, bacteria need to divide. Thus, bacterial cell division has emerged as a promising antibiotic target pathway to combat multi-resistant pathogens.

 This project aims to target the protein-protein interactions that bacteria use during cell division to specifically target pathogenic bacteria. Using Mycobacteria smegmatis as a model of Mycobacteria tuberculosis, the project will design, synthesise and test compounds which target specific bacterial cell division.

This chemical biology and microbiology project will be interdisciplinary, involving training in the computational design and synthesis of peptides and small molecules, the analysis of compounds binding to proteins and their activity in bacterial cells. Led by Dr Andrew Beekman, Dr Susan Schlimpert and Professor Mark Searcey, there is an opportunity to learn medicinal chemistry, protein biophysics, bacterial cell biology and molecular microbiology

The project will be based in the School of Pharmacy, University of East Anglia and the Department of Molecular Microbiology, John Innes Centre, a world-leading institute for plant and microbial research. The student will have access to cutting-edge research facilities for bacterial genetics, live cell imaging and protein biochemistry, a vibrant graduate student community and a stimulating research environment.

Through the project and the range of training opportunities available at the institute the student will obtain excellent technical and transferable skills that are highly relevant for working in academia or industry.

You will have, or expect to obtain a first class, 2(i) or equivalent Honours degree in Chemistry, Biochemistry, Pharmacy or related area.

Informal enquiries are welcomed: Dr Andrew Beekman ([Email Address Removed]) or Dr Susan Schlimpert ([Email Address Removed])

For more information on the supervisor for this project, please visit the UEA website 

The start date is 1 October 2022

Entry Requirements: Acceptable first degree 2:1 in Chemistry, Biochemistry, Pharmacy or related area

Funding Notes

This PhD project is offered on a self-funding basis. It is open to applicants with funding or those applying to funding sources. Details of tuition fees can be found at
A bench fee is also payable on top of the tuition fee to cover specialist equipment or laboratory costs required for the research. Applicants should contact the primary supervisor for further information about the fee associated with the project.


i) eLife 2021,10, e63387 DOI: 10.7554/eLife.63387
Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.

PhD saved successfully
View saved PhDs